1 Healthcare Stock Set to Rebound in 2026

MrDecoder · 2026-03-18T01:13:31+00:00

UnitedHealth Group has faced significant stock declines recently but is poised for a rebound in 2026. Despite challenges from higher costs and negative publicity, operational improvements and efficient strategies could drive recovery and growth in earnings.

MrDecoder

2026-03-18 01:13:31

Abstract generation in progress

It’s been a rough patch for UnitedHealth Group (UNH +0.74%) over the past couple of years. After its stock dropped by around 35% in 2025, it has continued to decline, down over 13% in 2026.

Despite its recent stock price struggles, I believe most of the company’s largest issues are in the rearview, and it’s set to rebound in 2026.

Expand

NYSE: UNH

UnitedHealth Group

Today’s Change

(0.74%) $2.10

Current Price

$287.59

Key Data Points

Market Cap

$259B

Day’s Range

$284.88 - $288.94

52wk Range

$234.60 - $606.36

Volume

197K

Avg Vol

Dividend Yield

3.10%

UnitedHealth’s struggles have been driven by higher costs, negative publicity, and a potentially flat Medicare Advantage payment rate in 2027. But in my opinion, many of these woes have been priced into the stock, and investors are taking for granted just how dominant UnitedHealth continues to be. It’s still one of the world’s largest healthcare companies, with a large presence in both insurance and care.

This year, many of UnitedHealth’s biggest issues are expected to improve. It’s planning to become more efficient by scaling back its Medicare Advantage footprint by discontinuing some plans, streamlining operations to reduce operating costs, and leaning into artificial intelligence (AI) to improve productivity.

Assuming these plans play out as expected, UnitedHealth should be set for a rebound. The company expects its revenue to dip slightly from 2025 ($447.6 billion to $439 billion), but its earnings are expected to return to growth. And trading at only 15.8 times its projected earnings over the next 12 months, the stock seems to have way more upside than downside.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.